Negative Results of Clinical Trials Given to FDA May Go Unpublished

Unfavorable industry-sponsored drug studies may wind up buried in the bowels of the FDA after the agency's scrutiny, never coming to light in the open medical literature, said researchers. But trials with results that cast a drug's safety and efficacy favorably are more likely to emerge in the literature, reported Lisa Bero, Ph.D., of the University of California San Francisco, and colleagues online in Public Library of Science Medicine. FULL ARTICLE HERE